Works matching DE "T cells"

Results: 5000
    1
    2

    Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8 T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer.

    Published in:
    OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1017702
    By:
    • Vassilev, L;
    • Ranki, T;
    • Joensuu, T;
    • Jäger, E;
    • Karbach, J;
    • Wahle, C;
    • Partanen, K;
    • Kairemo, K;
    • Alanko, T;
    • Turkki, R;
    • Linder, N;
    • Lundin, J;
    • Ristimäki, A;
    • Kankainen, M;
    • Hemminki, A;
    • Backman, C;
    • Dienel, K;
    • von Euler, M;
    • Haavisto, E;
    • Hakonen, T
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.

    Published in:
    OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008850
    By:
    • Calcinotto, Arianna;
    • Ponzoni, Maurilio;
    • Ria, Roberto;
    • Grioni, Matteo;
    • Cattaneo, Elena;
    • Villa, Isabella;
    • Bertilaccio, Maria Teresa Sabrina;
    • Chesi, Marta;
    • Rubinacci, Alessandro;
    • Tonon, Giovanni;
    • Bergsagel, P Leif;
    • Vacca, Angelo;
    • Bellone, Matteo
    Publication type:
    Article
    14

    Are BiTEs the “missing link” in cancer therapy?

    Published in:
    OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008339
    By:
    • Suryadevara, Carter M;
    • Gedeon, Patrick C;
    • Sanchez-Perez, Luis;
    • Verla, Terence;
    • Alvarez-Breckenridge, Christopher;
    • Choi, Bryan D;
    • Fecci, Peter E;
    • Sampson, John H
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    Time to Akt.

    Published in:
    OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2014.1003016
    By:
    • van der Waart, Anniek B;
    • Hobo, Willemijn;
    • Dolstra, Harry
    Publication type:
    Article
    23
    24
    25
    26

    Rapid generation of NY-ESO-1-specific CD4 T HELPER 1 cells for adoptive T-cell therapy.

    Published in:
    OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2014.1002723
    By:
    • Kayser, Simone;
    • Boβ, Cristina;
    • Feucht, Judith;
    • Witte, Kai-Erik;
    • Scheu, Alexander;
    • Bülow, Hans-Jörg;
    • Joachim, Stefanie;
    • Stevanović, Stefan;
    • Schumm, Michael;
    • Rittig, Susanne M;
    • Lang, Peter;
    • Röcken, Martin;
    • Handgretinger, Rupert;
    • Feuchtinger, Tobias
    Publication type:
    Article
    27
    28

    Consensus nomenclature for CD8 T cell phenotypes in cancer.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.998538
    By:
    • Apetoh, Lionel;
    • Bonneville, Marc;
    • Butterfield, Lisa H.;
    • Caignard, Anne;
    • Castelli, Chiara;
    • Cavallo, Federica;
    • Celis, Esteban;
    • Chen, Lieping;
    • Dhodapkar, Madhav V.;
    • Colombo, Mario P.;
    • Comin-Anduix, Begoña;
    • Ribas, Antoni;
    • Coukos, Georges;
    • Romero, Pedro;
    • Speiser, Daniel E.;
    • Dranoff, Glenn;
    • Frazer, Ian H.;
    • Fridman, Wolf-Hervé;
    • Gabrilovich, Dmitry I.;
    • Gilboa, Eli
    Publication type:
    Article
    29

    GITR agonist enhances vaccination responses in lung cancer.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.4161/2162402X.2014.992237
    By:
    • Zhu, Li X;
    • Srivastava, Minu K;
    • Huang, Min;
    • Lee, Jay M;
    • Dubinett, Steven;
    • Sharma, Sherven;
    • Kachroo, Puja;
    • St. John, Maie;
    • Davoodi, Michael;
    • Harris-White, Marni;
    • Strieter, Robert M
    Publication type:
    Article
    30
    31
    32
    33

    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.1001217
    By:
    • Schmitz-Winnenthal, Friedrich H;
    • Weitz, Jürgen;
    • Ulrich, Alexis;
    • Buechler, Markus W;
    • Pianka, Frank;
    • Klaiber, Ulla;
    • Diener, Markus;
    • Leowardi, Christine;
    • Schimmack, Simon;
    • Sisic, Leila;
    • Keller, Anne-Valerie;
    • Koc, Ruhan;
    • Knebel, Philipp;
    • Schmidt, Thomas;
    • Hohmann, Nicolas;
    • Mikus, Gerd;
    • Haefeli, Walter E;
    • Niethammer, Andreas G;
    • Breiner, Klaus M;
    • Friedrich, Tobias
    Publication type:
    Article
    34
    35
    36

    Tregs activated by bispecific antibodies.

    Published in:
    OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.994441
    By:
    • Koristka, Stefanie;
    • Cartellieri, Marc;
    • Arndt, Claudia;
    • Feldmann, Anja;
    • Seliger, Barbara;
    • Ehninger, Gerhard;
    • Bachmann, Michael P.
    Publication type:
    Article
    37
    38
    39
    40
    41

    CD /FOXP -ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.

    Published in:
    OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.990800
    By:
    • Fritzsching, Benedikt;
    • Fellenberg, Joerg;
    • Moskovszky, Linda;
    • Sápi, Zoltan;
    • Krenacs, Tibor;
    • Machado, Isidro;
    • Poeschl, Johannes;
    • Lehner, Burkhard;
    • Szendrõi, Miklos;
    • Bosch, Antonio Llombart;
    • Bernd, Ludger;
    • Csóka, Monika;
    • Mechtersheimer, Gunhild;
    • Ewerbeck, Volker;
    • Kinscherf, Ralf;
    • Kunz, Pierre
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50